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Abstract
Arterial spin labeling (ASL) provides absolute quantification of resting tissue cerebral blood flow
(CBF) as an entirely noninvasive approach with good reproducibility. As a result of neurovascular
coupling, ASL provides a useful marker of resting neuronal activity. Recent ASL studies in individu-
als at clinical high risk of psychosis (CHR) have reported increased resting hippocampal perfusion
compared with healthy controls. Schizotypy refers to the presence of subclinical psychotic-like
experiences in healthy individuals and represents a robust framework to study neurobiological
mechanisms involved in the extended psychosis phenotype while avoiding potentially confounding
effects of antipsychotic medications or disease comorbidity. Here we applied pseudo-continuous
ASL to examine differences in resting CBF in 21 subjects with high positive schizotypy (HS) relative
to 22 subjects with low positive schizotypy (LS), as determined by the Oxford and Liverpool Inven-
tory of Feelings and Experiences. Based on preclinical evidence that hippocampal hyperactivity
leads to increased activity in mesostriatal dopamine projections, CBF in hippocampus, midbrain,
and striatum was assessed. Participants with HS showed higher CBF of the right hippocampus
compared to those with LS (p5 .031, family-wise error corrected). No differences were detected
in the striatum or midbrain. The association between increased hippocampal CBF and HS supports
the notion that hippocampal hyperactivity might be a central characteristic of the extended psy-
chosis phenotype, while hyperactivity in subcortical dopamine pathways may only emerge at a
higher intensity of psychotic experiences.
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1 | INTRODUCTION
Healthy brain function relies on the appropriate regulation of
regional cerebral blood flow (CBF) for the delivery of oxygen and
glucose to support brain metabolism. Over the past decade, arterial
spin labeling (ASL) has emerged as a robust and noninvasive method
for acquiring regional CBF maps (Hernandez-Garcia, Lahiri, &
Schollenberger, 2018) with high reproducibility (Gevers et al., 2011;
Hermes et al., 2007). In contrast to imaging methodologies that
depend on the administration of a contrast agent to measure
perfusion, such as dynamic susceptibility contrast (DSC)-magnetic
resonance imaging (MRI), computed tomography (CT) perfusion
imaging, single-photon emission tomography (SPECT), and H2[
15O]
positron emission tomography (PET), ASL generates an image by
magnetically “labeling” water molecules as an endogenous tracer
(Williams, Detre, Leigh, & Koretsky, 1992). The difference between
labeled and unlabeled water within the blood reveals parenchymal
perfusion, an indirect yet highly correlated measure of neuronal
function, in units of milliliters of blood per 100 g of tissue per minute
(Alsop et al., 2015). Due to its noninvasive nature and ability to
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quantitatively measure tissue perfusion, ASL is currently used in rou-
tine clinical practice in cerebrovascular disease and neuro-oncology,
and there is a growing interest in its research and clinical applica-
tions to psychiatric disease (Grade et al., 2015).
While the anatomy of psychosis involves multiple brain regions and
networks, postmortem, preclinical, and clinical imaging studies demon-
strate a critical role of the hippocampus in its pathophysiology (Grace,
2010; Heckers, 2001; Tamminga, Stan, & Wagner, 2010). Most studies of
resting perfusion in patients with schizophrenia spectrum disorders rela-
tive to healthy controls, thus, focused predominantly on the hippocampal
region. Overall, these studies reported seemingly mixed results, including
increases (Friston, Liddle, Frith, Hirsch, & Frackowiak, 1992; Liddle et al.,
1992; Malaspina et al., 2004; Pinkham et al., 2011; Schobel et al., 2009,
2013; Talati et al., 2014; Talati, Rane, Skinner, Gore, & Heckers, 2015),
decreases (Kindler et al., 2015; Nordahl et al., 1996; Scheef et al., 2010;
Tamminga et al., 1992), or no differences (Horn et al., 2009; Ota et al.,
2014; Vita et al., 1995). Beyond the hippocampus, other brain regions of
significantly elevated resting perfusion in schizophrenia patients compared
with healthy controls have involved the basal ganglia and middle temporal
lobes (Pinkham et al., 2011), cerebellum, brainstem, and thalamus (Scheef
et al., 2010). Noteworthy, while not directly focusing on the hippocampus
as a specific region, initial PET and SPECT studies did not find increased
perfusion in medial temporal regions (Andreasen et al., 1997; Catafau
et al., 1994; Early, Reiman, Raichle, & Spitznagel, 1987; Parellada et al.,
1994). A possible source for the inconsistencies noted among individual
studies is that resting perfusion research in patients with schizophrenia is
complicated by antipsychotic exposure (Lahti et al., 2006; Lahti, Weiler,
Holcomb, Tamminga, & Cropsey, 2009; Medoff, Holcomb, Lahti, & Tam-
minga, 2001). In this context, recent studies in mostly antipsychotic-free
subjects at clinical high risk of developing psychosis (CHR) compared to
healthy controls have found that resting perfusion is increased in hippo-
campus (Allen et al., 2016, 2017; Schobel et al., 2013), striatum (Allen
et al., 2016, 2017; Kindler et al., 2018), and midbrain (Allen et al., 2016,
2017). These findings are consistent with data from preclinical models of
psychosis which propose a key role for hippocampal hyperactivity in the
emergence of psychotic-like neurobiological and behavioral phenotypes
by disrupting subcortical tonic dopamine neuron firing (Lodge & Grace,
2011). Furthermore, multimodal imaging studies in CHR subjects have
demonstrated that hypermetabolism of the hippocampus predicts hippo-
campal volume loss that is associated with increased glutamate levels
(Schobel et al., 2013), and that resting hippocampal perfusion is related to
medial prefrontal GABA1 levels in CHR subjects, particularly in those
who subsequently develop a psychotic disorder (Modinos et al., 2018). On
the basis of the observation of heightened hippocampal perfusion in
patients with psychotic disorders (Friston et al., 1992; Liddle et al., 1992;
Malaspina et al., 2004; Pinkham et al., 2011; Schobel et al., 2009, 2013;
Talati et al., 2014, 2015) and in CHR individuals (Allen et al., 2016, 2017;
Schobel et al., 2013), hippocampal hyperperfusionmight be a central char-
acteristic of the extended psychosis phenotype.
The continuum model of psychosis posits dimensional continuity
between subclinical psychotic-like experiences in healthy individuals
(termed schizotypy) and psychotic symptoms in patients with schizophre-
nia spectrum disorders (Linscott & van Os, 2013; Nelson, Seal, Pantelis,
& Phillips, 2013). The high schizotypy (HS) paradigm involves healthy
people who are typically non-help-seeking and have thus not been
exposed to antipsychotic medication. HS individuals can be identified
using psychometrically validated self-report instruments such as the
Oxford and Liverpool Inventory of Feelings and Experiences (O-LIFE)
(Mason, Linney, & Claridge, 2005). With a large body of
evidence supporting shared genetic, environmental, neurobiological, and
cognitive-emotional factors between HS and psychotic disorders (Bar-
rantes-Vidal, Grant, & Kwapil, 2015; Ettinger, Meyhofer, Steffens, Wag-
ner, & Koutsouleris, 2014; Kwapil & Barrantes-Vidal, 2015; Nelson et al.,
2013), the continuummodel would predict that resting hippocampal per-
fusion is also elevated in individuals with subclinical psychotic-like expe-
riences. Although neuroimaging studies are yet to test this hypothesis,
HS individuals show elevated hippocampal responses to a range of cog-
nitive and emotional tasks (Bourque et al., 2017; Modinos et al., 2017b;
Mohanty et al., 2005). Thus, our study sought to investigatewhether hip-
pocampal hyperperfusion is present in this group, compared to a
matched group of people with low schizotypy. In addition, given that a
recent study has shown associations between positive schizotypy scores
and striatal functional connectivity at rest (including positive correlations
between ventral striatum-frontal cortex and negative correlations
between dorsal striatum–posterior cingulate cortex) (Wang, Ettinger,
Meindl, & Chan, 2018), and that vulnerability for psychosis has also been
associated with hyperperfusion in dopamine signaling regions such as
the striatum and the midbrain (Allen et al., 2016, 2017; Kindler et al.,
2018), which could arise downstream from hippocampal hyperactivity
(Lodge & Grace, 2011), we predicted that individuals with HS would also
show increased resting perfusion in these subcortical regions.
2 | MATERIALS AND METHODS
2.1 | Participants
The study had King’s College London Research Ethics Committee
approval and all participants gave written informed consent to the
study protocol. The study was conducted in compliance with the Code
of Ethics of the World Medical Association (Declaration of Helsinki).
The recruitment procedure has been described in detail in our
recent publications in a largely overlapping sample (Modinos et al.,
2017a,b). Briefly, 250 healthy individuals who responded to online
advertisement were prescreened with the short version of the O-LIFE
questionnaire (Mason et al., 2005). Following previous imaging research
in HS using the O-LIFE (Premkumar et al., 2012), volunteers scoring
high on the O-LIFE Unusual Experiences (UE) subscale (UE>7, HS
group) and volunteers scoring low (UE<2, LS group) were then invited
to participate. The UE subscale of the O-LIFE was used as it is associ-
ated with greater severity of positive symptoms in patients with psy-
chosis (Cochrane, Petch, & Pickering, 2010), and because positive
symptoms are the core criteria by which individuals at CHR of psycho-
sis have been recruited to previous ASL studies (Allen et al., 2016,
2017). The O-LIFE comprises three other subscales besides UE—includ-
ing cognitive disorganization, impulsive nonconformity, and introvertive
anhedonia—and a composite O-LIFE total score may also be computed.
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Twenty-one individuals were included in the HS group (10
females; age range, 18–44 years; mean age 26.62 years) and 22 in the
LS group (11 females; age range, 19–39 years; mean age 26.50 years).
Participants were excluded if they had a personal history of neuro-
logic/psychiatric disorders according to the Mini International Neuro-
psychiatric Inventory (Sheehan et al., 1998) as administered by a
trained researcher. Other exclusion criteria included contraindications
to MRI scanning, having a first-degree relative with present/past his-
tory of psychotic disorder, present/past history of use of psychotropic
medications, and use of recreational drugs in the two weeks prior to
scanning or meeting criteria for substance abuse/dependency by self-
report.
2.2 | Assessments
On the day of scanning, participants completed the following assess-
ments: a validated short version of the Wechsler Adult Intelligence
Scale-III (WAIS-III) to measure intelligence (Velthorst et al., 2013), a
semi-structured interview adapted from the Early Psychosis Prevention
and Intervention Centre (EPPIC) Drug and Alcohol Assessment Sched-
ule (http://www.eppic.org.au) to discard present/past use of antipsy-
chotic medication, and to record present/past use of alcohol, tobacco,
and cannabis; and the Social Functioning Questionnaire (SFQ) (Tyrer
et al., 2005).
2.3 | MRI acquisition
All scans were conducted on a General Electric Discovery MR750 3
Tesla system (General Electric, Chicago, IL) at the Institute of Psychia-
try, Psychology and Neuroscience, King’s College London using a 12-
channel head coil. A three-dimensional T1-weighted inversion recovery
prepared gradient echo sequence, required for the preprocessing of
the ASL images, was obtained (field of view: 270 mm, TR/TE/TI: 7.3/
3.0/400 ms, slice thickness51.2 mm, 196 slices), based on the
well-validated ADNI 2/ADNI GO protocols (http://adni.loni.usc.edu/
methods/documents/mri-protocols/).
A pseudo-continuous ASL sequence was acquired with a multi-
shot, segmented 3D stack of axial spirals (8 arms) readout with a result-
ant spatial resolution of 2 3 2 3 3 mm. Four control-label pairs were
used to derive a perfusion-weighted difference image (Dai, Garcia, de
Bazelaire, & Alsop, 2008). The labeling RF pulse consisted of a train of
one thousand Hanning-shaped RF pulses with a total duration of 1.5 s
and a postlabeling delay of 1.5 s was also used. This arterial blood RF
labeling scheme has been shown to have a remarkably consistent label-
ing efficiency over a wide range of arterial blood velocities (Dai et al.,
2008). The sequence included background suppression for optimum
reduction of the static tissue signal, and used TE511.088 ms,
TR54,923 ms, FoV5240. Following the labeling of arterial blood,
postlabeling delay and background suppression, the control and labeled
images were both read with a “3D Fast Spin Echo Stack of Spiral”
scheme (Thedens, Irarrazaval, Sachs, Meyer, & Nishimura, 1999).
Within the whole-brain excitation slab of the 3D scan, 56 “slice parti-
tions” of 3 mm thickness were used. In the in-plane direction, k-space
was sampled with a spiral raster consisting of 8 interleaved spiral arms
of 512 points each. This spread of points has an equivalent voxel size
(in-plane) of 3.2 3 3.2 mm, after the spiral distribution of points is
regridded into a rectangular matrix for Fourier Transformation. Once
reconstructed, the image was written to a resulting rectangular matrix
of 256 points in a 24 cm FoV, hence providing a final in-plane voxel
size of 2 3 2mm. As a result of the 1808 pulses employed in the 3D
“stack of spiral” Fast Spin Echo readout, any signal loss due to magnetic
susceptibility gradients is refocused. Hence, our CBF images do not
exhibit the well-known signal dropout observed in other ASL methods
that employ readout schemes such as Echo-Planar Imaging. Within the
same scanning series, a proton density image was acquired in 48 s
using the same acquisition parameters to compute the CBF map (from
the difference image) in standard physiological units (ml blood/100 g
tissue/min). The whole ASL pulse sequence, including the acquisition of
the proton density image, was performed in 6:08 min.
2.4 | Preprocessing
CBF maps were preprocessed using FMRIB Software Library (FSL)
software applications (http://www.fmrib.ox.a.c.uk/fsl) and Statistical
Parametric Mapping (SPM12; http://www.fil.ion.ucl.ac.uk/spm/). Com-







in which P is the signal in the perfusion-weighted image (control–label),
R is the signal in the reference image, E is the combined efficiency of
labeling and background suppression (65%), s is the labeling duration
(1.5s), T1a is the T1 of arterial water, and w is the postlabeling delay
(1.5 s).
A multi-step approach was performed for spatial normalization of
the CBF maps to the space of the Montreal Neurological Institute
(MNI): (a) co-registration of the proton density image to the T1-image
after realigning the origin of both images. The transformation matrix of
this co-registration step was then applied to the CBF map, to transform
the CBF map to the space of the T1-image; (b) unified segmentation of
the T1 image scan to generate a “brain-only” binary mask; (c) elimina-
tion of extracerebral signal from the CBF map, by multiplication of the
“brain only” binary mask above, with the CBF map in the space of the
T1 image; (d) normalization of the subject’s T1 and the skull-stripped
CBF map, using the parameters of the unified segmentation matrices.
Finally, spatial smoothing of the normalized individual CBF maps (an
example is shown in Figure 1) was carried out using a 6-mm Gaussian
smoothing kernel. A schematic view of the ASL preprocessing pipeline
is shown in Figure 2.
2.5 | Statistics
2.5.1 | Demographic data
Analyses of demographic data were performed in SPSS 24 (http://
www-01.ibm.com/software/uk/analytics/spss/). The effect of group
on these measures was examined using independent samples t tests
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for parametric data and Chi-square tests for nonparametric data. Signif-
icant effects are reported at p< .05.
2.5.2 | Mean global CBF
To assess potential group differences in global CBF, global CBF values
were extracted from each subject and an independent samples t test
was performed in SPSS.
2.5.3 | ROI analysis
Statistical analyses of regional CBF data were implemented in SPM12.
An independent samples t test was used to test for significant differen-
ces between the HS and LS groups using a voxel-wise region of inter-
est (ROI) approach. ROIs were specified a priori using the coordinates
from a previous CBF study comparing CHR subjects with healthy con-
trols (Allen et al., 2016): MNI coordinates in right x, y, z520, 228, 28
and left hippocampus x, y, z5222, 228, 28; basal ganglia: right x, y,
z522, 212, 24 and left x, y, z5218, 28, 24 pallidum/putamen; and
in the left midbrain x, y, z5210, 232, 218. These coordinates were
used for small volume correction (SVC) with a 6-mm sphere. Statistical
inferences were made at p< .05 with family-wise error (FWE) correc-
tion for multiple comparisons at the voxel level after applying SVC.
Mean global CBF was included as a covariate in the design matrix using
ANCOVA, to account for interindividual differences in global perfusion.
Within the HS group, exploratory correlations between CBF in
the hippocampal, basal ganglia and midbrain ROIs and severity of
psychotic-like experiences (O-LIFE Total, UE, cognitive disorganization,
impulsive nonconformity, and introvertive anhedonia scores) and with
social functioning levels (SFQ scores) were tested with separate regres-
sion analyses in SPM, adjusted for mean global rCBF and using p< .05
with FWE correction at the voxel-level after applying SVC.
Potential effects of age, gender, or substance use (alcohol, ciga-
rettes, and cannabis) on the imaging findings were examined by includ-
ing these variables as covariates of no interest in the SPM designs
described above for group comparisons and correlations. Finally, for
completeness, exploratory voxel-wise whole brain effects were also
assessed at a voxel-wise p< .05 FWE threshold.
3 | RESULTS
3.1 | Demographic and questionnaire data
Table 1 summarizes the demographic and O-LIFE questionnaire data in
the HS and LS groups. By design, the groups only differed significantly
in the schizotypy measure, with higher scores for the HS group in O-
LIFE Total (p< .001; Cohen d52.15), unusual experiences (p< .001;
Cohen d53.61), cognitive disorganization (p< .001; Cohen d51.22),
and introvertive anhedonia (p< .001; Cohen d51.51).
3.2 | ASL data
3.2.1 | Mean global CBF
Group average mean global CBF values (ml/100 g/min) for the HS
group were 48.8868.40, and for the LS group 49.3069.87, which did
not differ significantly (t(41)5 .152, p5 .880; Cohen d50.05).
3.2.2 | ROI analysis
The a priori ROI analysis revealed higher CBF in the right hippocampus
in subjects with HS compared to those with LS (MNI coordinates x, y,
z524, 230, 28; T53.25; Z53.04; k542; p5 .031 FWE-corrected;
Cohen d50.67) (Figure 3). There were no suprathreshold effects on
the left hippocampus, basal ganglia, or midbrain regions. Exploratory
voxel-wise whole-brain analysis did not reveal any significant
differences.
Both the higher CBF levels in the HS compared to the LS group
and the lack of further significant group differences remained apparent
when age, gender, alcohol, cigarette, and cannabis use were added to
the statistical model as covariates of no interest.
3.2.3 | Relationship between CBF and schizotypal or social
functioning scores
No significant voxel-wise correlations at p< .05 FWE were found
between regional CBF and any of the O-LIFE subscales or total score
or SFQ scores.
FIGURE 1 Representative subject-level cerebral blood flow map in normalized space. In green, overlaid anatomical hippocampal mask from
the Automated Anatomical Labeling atlas. The SNR in the hippocampus was measured to be 4.561.0, as obtained from a set of 10 inde-
pendent measures taken at random, by dividing the value of the perfusion induced signal over the noise and reporting the average. [Color
figure can be viewed at wileyonlinelibrary.com]
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4 | DISCUSSION
The main finding of this study is that individuals with high positive
schizotypy showed increased resting perfusion in the right hippocam-
pus compared to those with low schizotypy. This finding was not
attributable to group differences in global CBF levels. To our knowl-
edge, this is the first application of the ASL method to investigate dif-
ferences in resting perfusion in a schizotypy group. Given that the
study groups only differed on the presence of schizotypal traits, and
that hippocampal hyperperfusion has been reported in patients with
FIGURE 2 Arterial Spin Labeling preprocessing pipeline. [Color figure can be viewed at wileyonlinelibrary.com]
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psychosis (Friston et al., 1992; Liddle et al., 1992; Malaspina et al.,
2004; Pinkham et al., 2011; Schobel et al., 2009, 2013; Talati et al.,
2014, 2015; although see Andreasen et al., 1997; Catafau et al., 1994;
Early et al., 1987; Parellada et al., 1994), and in people at CHR of syc-
hosis (Allen et al., 2016, 2017; Schobel et al., 2013), our study findings
suggest that increased hippocampal activity (reflected in an elevation
of regional perfusion) is also involved in the expression of subclinical
psychotic-like experiences.
In terms of the clinical or functional correlates of CBF abnormal-
ities along the psychosis spectrum, previous longitudinal studies in
CHR individuals reported that (a) elevated hippocampal cerebral blood
volume as measured with the contrast agent gandolinium was linked to
the risk of later transition to psychosis (Schobel et al., 2009, 2013), (b)
increased hippocampal CBF as measured with ASL was subsequently
normalized in CHR subjects who remitted from their CHR state (Allen
et al., 2016), and (c) hippocampal CBF and medial prefrontal GABA1
concentrations were associated in CHR individuals who subsequently
developed a psychotic disorder (Modinos et al., 2018). Although the
observation of an increase in resting hippocampal perfusion in HS is
consistent with the majority of previous studies in CHR and schizo-
phrenia with a specific focus on the hippocampus, as discussed above,
the cross-sectional nature of the present study prevents investigating
whether this finding is prospectively linked to a subsequent emergence
of mental health disorders in schizotypy (Cannon et al., 2015). Further-
more, although the significant effect on our sample was restricted to
the right hippocampus, consistent with a recent study in CHR individu-
als compared to healthy controls (Allen et al., 2017), this observation is
only partly consistent with other studies in CHR subjects in which
hyperperfusion involved both hippocampi (Allen et al., 2016; Schobel
et al., 2013). The lack of significant effects in the left hippocampus may
be related to a lesser degree of psychosis risk, or to limited power in
this nonclinical sample, and this will need to be replicated by independ-
ent studies of larger samples.
Contrary to our second hypothesis derived from CHR studies
(Allen et al., 2016, 2017; Kindler et al., 2018), we did not find any group
TABLE 1 Demographic and questionnaire data
Characteristic Low schizotypy (n522) High schizotypy (n5 21) t/v2 p
Age (years) 26.5065.13 26.626 6.92 2.064 .949
Gender (male/female) 11/11 11/ 10 .024 .876
IQ (WAIS-III short version) 122.456 13.84 119.296 16.73 .678 .502
O-LIFE total 16.0568.78 [range: 4–33] 39.056 12.32 [range: 24–58] 27.022 <.001
O-LIFE unusual experiences 1.0061.02 [range: 0–3] 12.146 4.29 [range: 7–22] 211.585 <.001
O-LIFE cognitive disorganization 5.3664.02 [range: 0–12] 11.866 6.34 [range: 5–24] 23.989 <.001
O-LIFE introvertive anhedonia 4.8663.23 [range: 1–14] 9.1962.46 [range: 5–13] 24.926 <.001
O-LIFE impulsive nonconformity 4.8264.34 [range: 0–15] 5.8664.26 [range: 0–17] 2.792 .433
Social Functioning Questionnaire total 4.1463.11 5.6262.88 21.619 .113
Daily tobacco use .7463.27 326 .77 .549 .586
Alcohol use (median [range]) 2 (0–5) 1 (0–4) 5.017 .414
Marijuana use (median [range]) 1 (0–3) 0 (0–3) 1.818 .611
Parental socio-economic status (% salariat) 61.9% (n513) 73.7% (n514) 1.741 .419
Educational level (% postgraduate) 50% (n511) 38.1% (n58) 2.452 .653
Note. O-LIFE5Oxford–Liverpool Inventory of Feelings and Experiences. WAIS-III5Wechsler Adult Intelligence Scale-III. Cannabis/alcohol use:
05 never, 15 experimental use (has tried occasionally), 25occasional use (has used small quantities from time to time), 35moderate use (has used in
small quantities regularly/large amounts occasionally), 45 severe use (has frequently used large quantities, often to intoxication/debilitation).
For the Social Functioning Questionnaire, higher scores indicate greater social impairment.
FIGURE 3 Increased resting perfusion in subjects with high
positive schizotypy relative to subjects with low positive
schizotypy in the right hippocampus (p5 .031 FWE) and scatter
plot showing hippocampal cerebral blood flow (CBF) levels in each
group. [Color figure can be viewed at wileyonlinelibrary.com]
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differences in resting perfusion of the basal ganglia or midbrain. Mech-
anistically, animal models strongly implicate hippocampal hyperactivity
as a primary factor leading to downstream subcortical hyperdopaminer-
gia and psychotic-like behaviors (Lisman et al., 2008; Lodge & Grace,
2011). In contrast to CHR subjects, whilst individuals with HS endorse
experiencing psychotic-like phenomena of a subclinical nature, they are
not help-seeking, and have a lower likelihood of developing psychosis
than a CHR group (Kwapil, Gross, Silvia, & Barrantes-Vidal, 2013). As
the hypothesis derived from animal models is that hippocampal hyper-
activity is upstream from subcortical dopamine excess (Lodge & Grace,
2011), hippocampal hyperperfusion may be present to a lesser
(although significant) extent in non-help-seeking HS subjects than in
CHR individuals and patients with psychosis. As a consequence, the
increase in mesolimbic dopaminergic regions may not be present or
detectable in a sample of HS participants selected from a university
population, and this could reflect mechanisms of resilience in this
group. In CHR individuals, elevated striatal dopamine function is
observed to a lesser extent than in psychosis (Howes et al., 2009), and
this may further increase with transition to psychosis (Howes et al.,
2011). Although there is some evidence of an association between
altered dopaminergic neurotransmission and psychometrically identi-
fied schizotypy (Woodward et al., 2011), findings are less consistent
than in frank psychosis, possibly due to high heterogeneity in the
experimental designs and methods used (Mohr & Ettinger, 2014).
Moreover, elevated stress-induced dopamine release as measured with
[11C]raclopride PET (Soliman et al., 2008) and increased functional acti-
vation as measured with functional MRI (Soliman et al., 2011) in striatal
regions in schizotypy has only been observed in relation to negative
schizotypal features (reflecting the interpersonal dimension of schizo-
typy, thought to mirror negative symptoms in schizophrenia), but not in
relation to positive schizotypy (reflecting the cognitive-perception
dimension of schizotypy, thought to mirror positive symptoms in schiz-
ophrenia). Further research examining the relative contributions of
hyperperfusion at different nodes of a hippocampal–striatal–midbrain
circuit along a psychosis continuum (psychosis, CHR, and HS), com-
bined with measurements of the different neurotransmitter systems
involved (i.e., GABA, glutamate, and dopamine), may provide substantial
insights into the neurobiology of risk and resilience for psychiatric dis-
orders (Pantelis & Bartholomeusz, 2014). Considering that animal mod-
els have demonstrated a direct link between hippocampal excitation–
inhibition imbalance and hippocampal hyperactivity (Lodge, Behrens, &
Grace, 2009), and that GABAergic dysfunction is proposed as a key
driver of hippocampal hyperactivity in schizophrenia (Heckers & Kon-
radi, 2015), future preclinical studies could test whether selective sup-
pression of hippocampal interneurons is related to increases in
hippocampal CBF maps, and compare these to CBF maps in the
extended human psychosis phenotype to dissect the molecular mecha-
nisms underlying the dimensionality of psychotic experiences.
In terms of correlations with levels of psychopathology, this study
did not find significant associations between severity of subclinical
psychotic-like experiences or levels of social functioning and resting
perfusion in the hippocampus, basal ganglia, or midbrain. The two pre-
vious ASL studies in CHR subjects did also not observe significant
correlations between levels of prodromal symptoms and hippocampal
CBF (Allen et al., 2016, 2017). We cannot exclude the possibility that,
by selecting subjects scoring above a certain threshold to determine
high positive schizotypy, the range of O-LIFE symptom scores was lim-
ited in both groups. Studies including a wider spectrum of individuals
with schizotypy, subclinical, and overt psychosis may reveal relation-
ships between hippocampal CBF and psychotic symptom severity.
There are some limitations to this study. First, subjects were
recruited from a university sample, had relatively high IQs and groups
showed no differences in self-reported substance use; therefore, our
results may not generalize to all individuals with schizotypy. Larger
studies in samples drawn from the general population, and including
biological measures of substance use such as a urine test, will help
define the normal variation in schizotypy. Second, we selected individu-
als based on their scores on the unusual experiences subscale of the
O-LIFE and therefore the results reflect CBF changes associated with
the positive dimension of schizotypy. Future research studying individ-
uals on the basis of negative and disorganized schizotypal traits will be
able to expand on the dimensional specificity of the present findings.
Third, our sample was relatively small, and recruitment through self-
report has previously been related to higher rates in schizotypy scores
(Linscott & van Os, 2010). Replication in larger, independent samples
will be important to validate the current findings, perhaps including a
measure of psychotic-like experiences administered by a rater or clini-
cian. Fourth, the distribution of schizotypy in nonclinical samples as
measured with instruments such as the O-LIFE or the Community
Assessment of Psychic Experiences (CAPE) does not show a continu-
ous normal distribution, but a continuous half-normal distribution, with
the majority of the population having very low values while a signifi-
cant proportion has progressively higher values (van Os, Linscott,
Myin-Germeys, Delespaul, & Krabbendam, 2009). Furthermore, com-
pared to other measures of schizotypy which are based on personality
traits (e.g., Schizotypal Personality Questionnaire), the O-LIFE includes
more “pathological” items (e.g., does not tap on phenomena such as
daydreaming), so that very low scores are “normal.” Thus, we used low
scorers to reflect a normative group with absence of subclinical
psychotic-like experiences, although future studies including a control
group based of average scorers should help expand these findings.
Finally, in response to a reviewer recommendation, we tested for a
potential relationship between hippocampal CBF and gray matter vol-
ume in this region. Individual CBF values extracted from the hippocam-
pal region showing a significant group difference were introduced as
covariate in an ANCOVA design in SPM12, using gray matter segments
obtained after voxel-based morphometry preprocessing as reported in
a recent study by our group in this sample (Modinos et al., 2017a), fol-
lowing the proposal that GMV could represent a potential confounder
in ASL studies (Asllani, Borogovac, & Brown, 2008; Chappell et al.,
2011). This analysis yielded no significant effects within or between
groups either at p< .05 FWE or at a more lenient threshold of p< .001
uncorrected. Thus, the observed group differences in hippocampal CBF
in the present study are unlikely to be confounded by underlying GMV
effects from this region. Noteworthy, our recent multimodal structural
imaging study in this same sample did not find hippocampal volume
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differences between the groups (Modinos et al., 2017a), consistent
with all other neuroanatomical investigations in schizotypy (DeRosse
et al., 2015; Ettinger et al., 2012; Kuhn, Schubert, & Gallinat, 2012;
Modinos et al., 2010; Nenadic et al., 2015; Wang et al., 2015; Wiebels,
Waldie, Roberts, & Park, 2016).
5 | CONCLUSIONS
Healthy subjects with psychometrically identified positive schizotypy
show increases in resting perfusion of the hippocampal region as meas-
ured with ASL. These findings are consistent with preclinical and clini-
cal evidence suggesting that increases in resting perfusion of the
hippocampal region underlie the pathophysiology of high positive
schizotypy, and indicate that such hyperactivity is not secondary to
potential influences of disease chronicity or antipsychotic medication
on brain function. Future studies specifically comparing individuals with
different levels of psychotic-like or clinically relevant psychotic symp-
toms over time could confirm whether increased hippocampal CBF
represents a state or trait marker across the psychosis spectrum.
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